Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive
When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive
News
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
Heath Ponder named as member of the National Philanthropy Committee
The Leukemia & Lymphoma Society (LLS) Georgia - South Carolina Region is pleased to announce the appointment of Heath Ponder, Director- Strategic Comm…
News
FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype
Blinatumomab has received full approval from the FDA after long-term data confirmed its safety and efficacy.
News
37 Patient Organizations Applaud Proposed Rule to Rein in Short-Term Health Plans
Short-term health plans don’t offer typical health insurance benefits and don’t include consumer protections such as coverage for pre-existing conditi…
Research
Apply to the Career Development Program (CDP)
Supporting talented young early-career physicians and scientists. Go directly to the information page on the CDP application process or browse our…
Patient Education Webcasts
CAR T-cell Therapy in Patients of Advanced Age
Research
Kymera Therapeutics Presents Data Demonstrating Superior Efficacy of KT-253, a Potent and Selective Heterobifunctional MDM2 Degrader, in Preclinical Leukemia Models at the European Hematology Association Congress
WATERTOWN, Mass., June 09, 2023 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degr…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
